Unexa Korea

Unexa Korea is a South Korean healthtech platform company that specializes in integrating advanced biotechnology into daily consumer healthcare and wellness products. The company operates a network-based business model, utilizing its "WYTN" brand for healthcare and "COREDERM" for skincare solutions. A key milestone for the company was the 2026 strategic technology transfer from the U.S. biotech firm Mereon Bio, which provided Unexa Korea with next-generation drug-delivery platforms, including ion-network and stimulus-responsive release systems. Unexa Korea has established an extensive global R&D network through partnerships with prestigious academic societies in the fields of anti-aging, oncology, and regenerative medicine, such as the Society for Immunotherapy of Cancer (SITC). Its commercial product lineup includes the I-PRIME, D-LOOP, and B-FOCUS series, which aim to make sophisticated pharmaceutical technologies accessible for everyday use. The company's "Advanced Business System" (ABS) facilitates a sustainable innovation ecosystem by connecting clinical research with consumer habits.